Lucion is an influential professional venture capital institute.
Business Model:
Revenue: $22M
Employees: 201-500
Address: Jingshi Road 9999
City:
State: shanghai municipality
Zip: 250101
Country: CN
Lucion is an influential professional venture capital institute.
Contact Phone:
Contact Email:
Listed Exchange:
SSE
IPO Date:
12/25/1996
Ticker Symbol:
600783
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2019 | Ruiyi Biotechnology (Realbio Technology) | Series A | 15M |
3/2020 | Targene Medical | Series A | 0 |
12/2017 | CloverSec Labs | Series A | 10.3M |
6/2013 | Huashi Jingcheng | Angel Round | 487.4k |
8/2014 | KungFu Animation Group | Angel Round | 488.1k |
12/2021 | ABclonal | Series D | 0 |
10/2020 | 3D Medicines | Private Equity Round | 0 |
3/2018 | XGIMI | Corporate Round | 95M |
1/2020 | 3D Medicines | Venture Round | 0 |
1/2022 | SiBionics | Series C | 0 |
11/2018 | Airwing.ai | Series A | 2.9M |
12/2010 | Hoteam Software | Angel Round | 454.5k |
4/2016 | BayNexus | Series B | 3.1M |
10/2014 | DAYANG PARKING | Series B | 3.3M |
5/2022 | HemaCell | Series A | - |
4/2020 | APTBIO | Series A | 28.3M |
2/2021 | ABclonal | Series C | 0 |
10/2019 | WeMed | Series C | - |
12/2019 | Remegen | Private Equity Round | - |
4/2021 | WeMed | Series D | 46.2M |
8/2017 | Zhimai Yinqing | Seed Round | 1.5M |
1/2019 | LandSpace | Series B | 14.5M |
1/2023 | Meidong Huicheng | Venture Round | - |
1/2023 | Insyce | Series B | 21.8M |
5/2022 | HemaCell | Series A | - |
1/2022 | SiBionics | Series C | 0 |
12/2021 | ABclonal | Series D | 0 |
4/2021 | WeMed | Series D | 0 |
2/2021 | ABclonal | Series C | 0 |
10/2020 | 3D Medicines | Private Equity Round | 0 |
4/2020 | APTBIO | Series A | 0 |
3/2020 | Targene Medical | Series A | 0 |
1/2020 | 3D Medicines | Venture Round | 0 |
12/2019 | Remegen | Private Equity Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|